Development of maleimide-modified poly(N-(2-hydroxylpropyl)methacrylamide) as a novel mucoadhesive polymer for nasal drug delivery

Shan, X., Pola, R., Kaldybekov, D. B., Aspinall, S., Buang, F., Williams, A. C. ORCID: https://orcid.org/0000-0003-3654-7916, Etrych, T. and Khutoryanskiy, V. V. ORCID: https://orcid.org/0000-0002-7221-2630 (2025) Development of maleimide-modified poly(N-(2-hydroxylpropyl)methacrylamide) as a novel mucoadhesive polymer for nasal drug delivery. European Polymer Journal, 237. 114193. ISSN 0014-3057 doi: 10.1016/j.eurpolymj.2025.114193

Abstract/Summary

Nasal drug administration is an attractive option for systemic drug delivery, but it is often limited by inadequate nasal drug absorption. In this study, we investigated novel mucoadhesive poly(N-(2-hydroxypropyl)methacrylamide) (PHPMA)-based copolymers functionalised with maleimide moieties as formulations to enhance the retention of dosage forms on the nasal mucosa. PHPMA and its maleimide derivatives were synthesised using controlled radical polymerisation, resulting in polymers with well-defined structures, low dispersity, and variable maleimide functionality. Functionalisation of PHPMA with maleimide groups substantially improved its mucoadhesive properties. Importantly, copolymers with low maleimide content, which were nevertheless sufficient for mucoadhesion, showed no significant cytotoxicity against HEK293 cells and no mucosal irritation in a slug mucosal irritation assay. These PHPMA derivatives demonstrate excellent potential as mucoadhesive materials for developing dosage forms for nasal drug delivery.

Item Type	Article
URI	https://centaur.reading.ac.uk/id/eprint/123904
Identification Number/DOI	10.1016/j.eurpolymj.2025.114193
Refereed	Yes
Divisions	Life Sciences > School of Chemistry, Food and Pharmacy > School of Pharmacy > Pharmaceutics Research Group
Publisher	Elsevier
Download/View statistics	View download statistics for this item